Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.

Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G.

World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282. Review.

2.

The importance of a multidisciplinary approach to hepatocellular carcinoma.

Siddique O, Yoo ER, Perumpail RB, Perumpail BJ, Liu A, Cholankeril G, Ahmed A.

J Multidiscip Healthc. 2017 Mar 20;10:95-100. doi: 10.2147/JMDH.S128629. eCollection 2017. Review.

3.

Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma.

Ogawa K, Takada Y.

Transl Gastroenterol Hepatol. 2016 May 4;1:35. doi: 10.21037/tgh.2016.04.03. eCollection 2016. Review.

4.

Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation.

She WH, Cheung TT.

Transl Gastroenterol Hepatol. 2016 Apr 14;1:34. doi: 10.21037/tgh.2016.03.04. eCollection 2016. Review.

5.

Recent advances in understanding and managing liver transplantation.

Russo FP, Ferrarese A, Zanetto A.

F1000Res. 2016 Dec 21;5. pii: F1000 Faculty Rev-2895. doi: 10.12688/f1000research.8768.1. eCollection 2016. Review.

6.

LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA.

Sá GP, Vicentine FP, Salzedas-Netto AA, Matos CA, Romero LR, Tejada DF, Massarollo PC, Lopes-Filho GJ, Gonzalez AM.

Arq Bras Cir Dig. 2016 Nov-Dec;29(4):240-245. doi: 10.1590/0102-6720201600040007. English, Portuguese.

7.

Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study.

Wang P, Pu Y, Li H, Shi B, Zheng S, Zhong L.

Springerplus. 2016 Oct 18;5(1):1809. doi: 10.1186/s40064-016-3441-5. eCollection 2016.

8.
9.

Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience.

Hu Z, Zhong X, Zhou J, Xiang J, Li Z, Zhang M, Wu J, Jiang W, Zheng S.

Sci Rep. 2016 May 26;6:26487. doi: 10.1038/srep26487.

10.

Liver resection for hepatocellular carcinoma in patients with portal hypertension: the role of laparoscopy.

Belli A, Cioffi L, Russo G, Belli G.

Hepatobiliary Surg Nutr. 2015 Dec;4(6):417-21. doi: 10.3978/j.issn.2304-3881.2015.12.02.

11.

Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.

Tacher V, Duran R, Lin M, Sohn JH, Sharma KV, Wang Z, Chapiro J, Gacchina Johnson C, Bhagat N, Dreher MR, Schäfer D, Woods DL, Lewis AL, Tang Y, Grass M, Wood BJ, Geschwind JF.

Radiology. 2016 Jun;279(3):741-53. doi: 10.1148/radiol.2015141624. Epub 2015 Dec 16.

12.

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M.

World J Hepatol. 2015 Sep 18;7(20):2274-91. doi: 10.4254/wjh.v7.i20.2274. Review.

13.

Current and future treatments for hepatocellular carcinoma.

Schlachterman A, Craft WW Jr, Hilgenfeldt E, Mitra A, Cabrera R.

World J Gastroenterol. 2015 Jul 28;21(28):8478-91. doi: 10.3748/wjg.v21.i28.8478. Review.

14.

Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.

Yeh MM, Yeung RS, Apisarnthanarax S, Bhattacharya R, Cuevas C, Harris WP, Hon TL, Padia SA, Park JO, Riggle KM, Daoud SS.

World J Hepatol. 2015 Jun 18;7(11):1460-83. doi: 10.4254/wjh.v7.i11.1460. Review.

15.

Liver transplantation as a management of hepatocellular carcinoma.

Azzam AZ.

World J Hepatol. 2015 Jun 8;7(10):1347-54. doi: 10.4254/wjh.v7.i10.1347. Review.

16.

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC).

Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13.

17.

Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.

Hoffmann K, Ganten T, Gotthardtp D, Radeleff B, Settmacher U, Kollmar O, Nadalin S, Karapanagiotou-Schenkel I, von Kalle C, Jäger D, Büchler MW, Schemmer P.

BMC Cancer. 2015 May 11;15:392. doi: 10.1186/s12885-015-1373-z.

18.

Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.

Kaido T, Morita S, Tanaka S, Ogawa K, Mori A, Hatano E, Uemoto S.

Dis Markers. 2015;2015:425926. doi: 10.1155/2015/425926. Epub 2015 Apr 1.

19.

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC).

Gut Liver. 2015 May 23;9(3):267-317. doi: 10.5009/gnl14460.

20.

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation.

Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M.

World J Hepatol. 2015 Apr 8;7(4):649-61. doi: 10.4254/wjh.v7.i4.649. Review.

Supplemental Content

Support Center